公开(公告)号：US20140206762A1

公开(公告)日：2014-07-24

申请号：US13745740

申请日：2013-01-18

Applicant: Zheng Tao Han ,  Hung-Fong Chen

Inventor： Zheng Tao Han ,  Hung-Fong Chen

IPC: A61K31/215 ,  A61K45/06

CPC classification number: A61K31/215 ,  A61K31/14 ,  A61K31/23 ,  A61K31/573 ,  A61K31/60 ,  A61K33/06 ,  A61K45/06 ,  A61K2300/00

Abstract: Methods and compositions containing a phorbol ester or a derivative of a phorbol ester are provided for the treatment of chronic and acute conditions. Such conditions may be caused by disease, be symptoms or sequelae of disease. Chronic and acute conditions may be due to viral infections such as HIV and AIDS, neoplastic diseases stroke, kidney disease, urinary incontinence, autoimmune disorders, Parkinson's disease, prostate hypertrophy, aging, or the treatment of such diseases. Additional compositions and methods are provided which employ a phorbol ester or derivative compound in combination with at least one additional agent to yield more effective treatment tools against acute and chronic conditions in mammalian subjects.

Abstract translation: 提供含有佛波醇酯或佛波醇酯衍生物的方法和组合物用于治疗慢性和急性病症。 这种情况可能是由疾病，症状或后遗症引起的。 慢性和急性病症可能是由于艾滋病毒和艾滋病，肿瘤性疾病中风，肾脏疾病，尿失禁，自身免疫性疾病，帕金森病，前列腺肥大，衰老或这些疾病的治疗等病毒感染。 提供了另外的组合物和方法，其使用佛波醇酯或衍生化合物与至少一种另外的试剂组合，以产生针对哺乳动物受试者的急性和慢性病症的更有效的治疗工具。

公开(公告)号：US11564901B2

公开(公告)日：2023-01-31

申请号：US13745740

申请日：2013-01-18

Applicant: Zheng Tao Han ,  Hung-Fong Chen

Inventor： Zheng Tao Han ,  Hung-Fong Chen

IPC: A61K31/215 ,  A61K45/06 ,  A61K31/23 ,  A61K31/573 ,  A61K31/60 ,  A61K31/14 ,  A61K33/06

Abstract: Methods and compositions containing a phorbol ester or a derivative of a phorbol ester are provided for the treatment of chronic and acute conditions. Such conditions may be caused by disease, be symptoms or sequelae of disease. Chronic and acute conditions may be due to viral infections such as HIV and AIDS, neoplastic diseases stroke, kidney disease, urinary incontinence, autoimmune disorders, Parkinson's disease, prostate hypertrophy, aging, or the treatment of such diseases. Additional compositions and methods are provided which employ a phorbol ester or derivative compound in combination with at least one additional agent to yield more effective treatment tools against acute and chronic conditions in mammalian subjects.

公开(公告)号：US20160106698A9

公开(公告)日：2016-04-21

申请号：US13745740

申请日：2013-01-18

Applicant: Zheng Tao Han ,  Hung-Fong Chen

Inventor： Zheng Tao Han ,  Hung-Fong Chen

IPC: A61K31/215 ,  A61K45/06

CPC classification number: A61K31/215 ,  A61K31/14 ,  A61K31/23 ,  A61K31/573 ,  A61K31/60 ,  A61K33/06 ,  A61K45/06 ,  A61K2300/00

Abstract: Methods and compositions containing a phorbol ester or a derivative of a phorbol ester are provided for the treatment of chronic and acute conditions. Such conditions may be caused by disease, be symptoms or sequelae of disease. Chronic and acute conditions may be due to viral infections such as HIV and AIDS, neoplastic diseases stroke, kidney disease, urinary incontinence, autoimmune disorders, Parkinson's disease, prostate hypertrophy, aging, or the treatment of such diseases. Additional compositions and methods are provided which employ a phorbol ester or derivative compound in combination with at least one additional agent to yield more effective treatment tools against acute and chronic conditions in mammalian subjects.